Apidra 100 [iU]/mL

Apidra 100 [iU]/mL is a rapid-acting insulin glulisine injection used for managing blood glucose levels in diabetes. This solution is administered via subcutaneous or intravenous routes.

Apidra 100 [iU]/mL is primarily used to control high blood sugar levels in adults and children with diabetes. It works by helping the body absorb glucose from the bloodstream, making it useful for both meal-time and correctional insulin needs. This rapid-acting insulin is often used in conjunction with long-acting insulin to manage diabetes effectively.

Common effects of Apidra 100 [iU]/mL may include localized reactions at the injection site, such as redness or itching. Some users may experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. These effects vary among individuals and typically subside as the body adjusts to the medication.

Apidra 100 [iU]/mL should be stored properly to maintain its efficacy. It is important to check the solution for particles or discoloration before use. Always follow healthcare provider instructions for administration and monitor blood sugar levels regularly. Avoid sharing needles or syringes to prevent infection.

Apidra 100 [iU]/mL may interact with other medications, including oral hypoglycemic agents, beta-blockers, and corticosteroids. Alcohol consumption can also affect blood sugar levels, potentially enhancing the risk of hypoglycemia. Always inform your healthcare provider about all medications and supplements you are taking.